Page last updated: 2024-10-21

pk 11195 and Behavior Disorders

pk 11195 has been researched along with Behavior Disorders in 3 studies

PK-11195 : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 1-(2-chlorophenyl)isoquinoline-3-carboxylic acid with the amino group of sec-butylmethylamine

Research Excerpts

ExcerptRelevanceReference
"In general, neurodegenerative diseases have unpredictable clinical courses and timely effective treatment is not available."2.43Nuclear imaging of inflammation in neurologic and psychiatric disorders. ( de Vries, EF; Dierckx, RA; Klein, HC, 2006)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Milenkovic, VM1
Rupprecht, R1
Wetzel, CH1
de Vries, EF1
Dierckx, RA1
Klein, HC1
Ouchi, Y1

Reviews

3 reviews available for pk 11195 and Behavior Disorders

ArticleYear
The Translocator Protein 18 kDa (TSPO) and Its Role in Mitochondrial Biology and Psychiatric Disorders.
    Mini reviews in medicinal chemistry, 2015, Volume: 15, Issue:5

    Topics: Antipsychotic Agents; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Isoquinol

2015
Nuclear imaging of inflammation in neurologic and psychiatric disorders.
    Current clinical pharmacology, 2006, Volume: 1, Issue:3

    Topics: Anti-Bacterial Agents; Antiviral Agents; Carbon Radioisotopes; Cyclooxygenase 2; Encephalitis; Human

2006
[Imaging of brain microgliosis by PET].
    Rinsho shinkeigaku = Clinical neurology, 2009, Volume: 49, Issue:11

    Topics: Animals; Brain; Carbon Radioisotopes; Cytokines; Humans; Isoquinolines; Mental Disorders; Microglia;

2009